Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.6%

8 terminated/withdrawn out of 220 trials

Success Rate

91.9%

+5.4% vs industry average

Late-Stage Pipeline

16%

35 trials in Phase 3/4

Results Transparency

8%

7 of 91 completed trials have results

Key Signals

39 recruiting7 with results7 terminated

Enrollment Performance

Analytics

N/A
95(53.1%)
Phase 2
33(18.4%)
Phase 3
26(14.5%)
Phase 1
14(7.8%)
Phase 4
9(5.0%)
Early Phase 1
2(1.1%)
179Total
N/A(95)
Phase 2(33)
Phase 3(26)
Phase 1(14)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (220)

Showing 20 of 220 trials
NCT06510699Phase 2Recruiting

Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial

Role: collaborator

NCT07532070Not ApplicableNot Yet Recruiting

COMPARATIVE EFFECTIVENESS OF EXERCISE, COGNITIVE BEHAVIOURAL THERAPY, AND THEIR COMBINATION FOR PEOPLE WITH CHRONIC MUSCULOSKELETAL PAIN AND POOR SLEEP: SLEEPFIT TRIAL

Role: lead

NCT06360939Not ApplicableRecruiting

Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease

Role: collaborator

NCT06257134Not ApplicableRecruiting

Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.

Role: collaborator

NCT07382310Not ApplicableCompleted

Effect of Different Products to Support Plaque Control During Daytime

Role: collaborator

NCT02514512Not ApplicableActive Not Recruiting

Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking

Role: collaborator

NCT04310891Active Not Recruiting

Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging for Lung Cancer Radiotherapy

Role: collaborator

NCT04334759Phase 3Completed

DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

Role: collaborator

NCT06976710Not ApplicableRecruiting

PRIORITY-CONNECT 2 Trial

Role: collaborator

NCT06983769Not ApplicableRecruiting

CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial

Role: collaborator

NCT01320345Phase 3Active Not Recruiting

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

Role: lead

NCT03825835Not ApplicableRecruiting

30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants

Role: collaborator

NCT07305376Not ApplicableEnrolling By Invitation

Older Adults' Attitudes Towards Stopping Aspirin

Role: collaborator

NCT05067569Not ApplicableCompleted

App-delivered Sleep ThERapy for Older Individuals With Insomnia

Role: collaborator

NCT07292519Phase 2Not Yet Recruiting

Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)

Role: collaborator

NCT06065384Not ApplicableRecruiting

Neural Plasticity and Motor Recovery After Upper Extremity Motor Training in People With c-SCI

Role: collaborator

NCT06148025Phase 4Recruiting

Antibiotics and Vaccine Immune Responses Study

Role: collaborator

NCT05846087Not ApplicableCompleted

Mobile App-delivered Sleep Therapy (SleepFix) for Individuals With Chronic Low Back Pain and Insomnia

Role: collaborator

NCT07255807Not ApplicableNot Yet Recruiting

Defining the Human Insulin Resistance Molecular Network; SIGNATURE

Role: collaborator

NCT03517865Active Not Recruiting

International Primary Ciliary Dyskinesia Cohort

Role: collaborator